focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSUMM.L Share News (SUMM)

  • There is currently no data for SUMM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Thursday broker round-up UPDATE

Thu, 22nd Aug 2013 07:25

Aggreko: RBC Capital reduces target price from 1850p to 1680p, while its neutral rating remains unchanged.Aviva: JP Morgan raises target price from 393p to 436p and retains an overweight rating.BHP Billiton: Canaccord Genuity takes target price from 1950p to 2050p maintaining a hold recommendation.Cairn Energy: RBC Capital moves target price from 440p to 450p and reiterates its outperform rating.Cropper (James): Westhouse Securities ups target price from 300p to 350p, while downgrading to add.Faroe Petroleum: Liberum Capital lowers target price from 188p to 183p, while leaving its buy recommendation unchanged.Ferrexpo: Cantor Fitzgerald reduces target price from 373p to 290p, but stays with its buy recommendation.Glencore Xstrata: JP Morgan cuts target price from 410p to 390p retaining its overweight rating.Hikma Pharmaceuticals: Jefferies ups target price from 1200p to 1250p and keeps a buy recommendation.Hochschild Mining: Westhouse Securities increases target price from 150p to 200p and reiterates a neutral rating. JP Morgan moves target price from 75p to 80p, while keeping an underweight rating. Citi shifts target price from 133p to 132p and maintains its sell recommendation. RBC Capital ups target price from 220p to 260p and stays with its neutral rating.IMI: Investec places both its target price (prev.: 1350p) and its hold recommendation under review.Intertek Group: Credit Suisse reduces target price from 3850p to 3600p, while retaining an outperform rating.IP Group: Numis lowers target price from 129p to 124p, while its hold recommendation remains unchanged.John Wood Group: JP Morgan cuts target price from 963p to 951p and stays with its neutral rating. Liberum Capital reduces target price from 892p to 874p.Legal & General Group: Morgan Stanley moves target price from 184p to 192p and maintains an equal-weight rating.Lloyds Banking Group: Jefferies shifts target price from 65p to 69p reiterating a hold recommendation.Sportech: Investec lowers target price from 110p to 105p and leaves its buy recommendation unaltered.Stagecoach Group: Deutsche Bank raises target price from 330p to 350p staying with its buy recommendation.Summit Corporation: N+1 Singer shifts target price from 8.80p to 10.70p keeping its buy recommendation.Vitec Group: Investec increases target price from 740 to 810p and retains a buy recommendation.Wolseley: UBS upgrades from neutral to buy with a target price of 3500p.
More News
12 Feb 2015 16:47

UK AGM, EGM Calendar - Week Ahead

Read more
2 Feb 2015 11:05

REPEAT: Summit Corp Plans Dual NASDAQ Listing, Name Change As Loss Widens (ALLIPO)

Read more
2 Feb 2015 09:38

Summit Corp Plans Dual NASDAQ Listing, Name Change As Loss Widens

Read more
8 Oct 2014 07:48

Summit Reports Positive Data At World Muscle Society Congress

Read more
8 Sep 2014 08:24

Summit Corp Says Studies Show Its SMT19969 Superior To Vancomycin

Read more
4 Sep 2014 09:58

Summit Corp Widens Loss As It Progresses Drugs Through Trials

Read more
30 Jul 2014 16:48

Summit chief buys 30,000 shares

AIM-listed drug developer Summit, which develops therapies for Duchenne Muscular Dystrophy and C. difficile infection, on Wednesday said its chief executive Glyn Edwards had acquired 30,000 shares. The 104.5p-a-share deal cost Edwards £31,350 and took his stake in the group to 233,333 shares. The

Read more
9 Jul 2014 07:37

UK MORNING BRIEFING: Deutsche Bank Raises Shell View, Cuts BP

Read more
7 Jul 2014 08:10

Summit Sees Positive Duchenne Muscular Dystrophy Drug Trial Results

Read more
3 Jul 2014 08:25

Summit Says First Patients In Phase II Antibiotic Trial Dosed

Read more
3 Jul 2014 07:33

UK MORNING BRIEFING: Tullow Oil Strikes Oil Offshore Norway

Read more
23 Jun 2014 07:27

UK MORNING BRIEFING: Shares Down As Iraq Fighting Lifts Oil Prices

Read more
23 Jun 2014 06:52

Summit Corp Appoints Erik Ostrowski As Chief Financial Officer

Read more
3 Jun 2014 08:52

Summit Corp To Consolidate Share Capital, Hoping To Get New Investors

LONDON (Alliance News) - Summit Corporation PLC Tuesday said it will seek shareholder permission for a share consolidation that will see every 20 existing shares consolidated into one new share. In a statement, the drug discovery company said it will first consolidate every 20 shares into o

Read more
21 May 2014 12:43

Summit Corp. reports progress with DMD trial, but next phase delayed

Shares in Summit Corporation suffered a fall despite giving a generally positive report of the first phase of its Duchenne Muscular Dystrophy (DMD) trial which has examined the safety and tolerance of SMT C1100. The decline may be linked to a delay in the next patient study, which is expected to no

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.